Attention Lab Directors: Four CLIA Updates from the Past Year to Examine
CMS tweaked its CE, documentation, and on-site visit requirements for directors
CLIA-lca
Subscribe today for access to
Articles and Reports
Clinical Lab Training Documentation Becomes More Important with CMS Revision
Third-party verification of lab personnel experience is now a CLIA requirement
FDA Watch: Mass Spectrometry Test Receives First Moderate Complexity Designation
Roche’s vitamin D assay includes internal quality controls that allowed it to obtain the CLIA designation
Analytic Systems Account for 5 of Top 10 Most Cited CLIA Deficiencies
CMS has published its list of top 10 most frequently cited Clinical Laboratory Improvement Amendments deficiencies for the previous year.
After Nearly 3 Decades, CMS Proposes Updates to Proficiency Testing Rules
...
Already a member? Log in here
Brief Your CEO: After 36 Years, CLIA Comes Under CMS Review
From - G2 Compliance Advisor
Even as your lab makes the transition to the new, supposedly market-based PAMA Medicare Part B fee schedule for tests, big changes may be in store for another rock of…
CLIA Corner: FDA Moves to Boost CLIA Waiver Transparency
...
Already a member? Log in here
Theranos Faces New Challenges and Increasing Federal Scrutiny
...
Already a member? Log in here
CMS Issues Deficiency Letter to Theranos
...
Already a member? Log in here
FDA’s 2016 Guidance Plans Include LDTs and Other Diagnostics Topics
...
Already a member? Log in here
FDA and CMS Address LDT Regulation Before Energy and Commerce Committee
...
Already a member? Log in here